B4GALNT1 antibody
Principal name
B4GALNT1 antibody
Alternative names for B4GALNT1 antibody
GALGT, SIAT2, GM2/GD2 synthase, GalNAc-T, Beta-1,4 N-acetylgalactosaminyltransferase 1, (N-acetylneuraminyl)-galactosylglucosylceramide
Ncbi ID
9606, NP_001469.1, NP_001469, NP_032106.1, NM_027739, NM_008080, NM_022860
Available reactivities
Available hosts
Available applications
Enzyme Immunoassay (E), Western blot / Immunoblot (WB), ELISA (detection) (E(detection)), Immunoprecipitation (IP)
Background of B4GALNT1 antibody
- Kit Component:
- - KN301931G1, B4galnt1 gRNA vector 1 in pCas-Guide vector
- KN301931G2, B4galnt1 gRNA vector 2 in pCas-Guide vector
- KN301931D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual
General readings
Gornati,R., Mol. Cell. Biochem. 298 (1-2), 59-68 (2007)
B4GALNT1 monoclonal antibody (M02), clone 5F9 Western Blot analysis of B4GALNT1 expression in HeLa ( Cat # L013V1 ).
B4GALNT1 monoclonal antibody (M02), clone 5F9. Western Blot analysis of B4GALNT1 expression in PC-12 ( Cat # L012V1 ).
Detection limit for recombinant GST tagged B4GALNT1 is approximately 0.1ng/ml as a capture antibody.
Western Blot analysis of B4GALNT1 expression in transfected 293T cell line (H00002583-T01) by B4GALNT1 MaxPab polyclonal antibody.Lane 1: B4GALNT1 transfected lysate(36.08 KDa).Lane 2: Non-transfected lysate.
Human HepG2; WB Suggested Anti-B4GALNT1 Antibody Titration: 0.2-1 ug/ml. Positive Control: HepG2 cell lysate; B4GALNT1 antibody - N-terminal region (ARP45116_P050) in Human HepG2 cells using Western Blot
Western Blot analysis of B4GALNT1 expression in transfected 293T cell line (H00002583-T01) by B4GALNT1 MaxPab polyclonal antibody.Lane 1: B4GALNT1 transfected lysate(35.50 KDa).Lane 2: Non-transfected lysate.
Western blot analysis of B4GALNT1 expression in MDAMB453 (A); A549 (B); K562 (C) whole cell lysates.
Western blot analysis of extracts from HeLa cells, K562 cells, HepG2 cells and HuvEC cells, using B4GALNT1 antibody.The lane on the right is treated with the synthesized peptide.
Primary Antibodies
| Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
|---|---|---|---|---|---|---|---|
| TA313910 | B4GALNT1 antibody |
||||||
| Rabbit polyclonal anti-B4GALNT1 antibody | |||||||
 |
Rabbit | IgG | Purified | Hu, Ms | E, WB |
0.1 ml /
€335.00
|
|
| OriGene Technologies, Inc. | |||||||
Mouse Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| MR208544L2V | Lenti ORF particles, B4galnt1 (GFP-tagged) - Mouse beta-1,4-N-acetyl-galactosaminyl transferase 1 (B4galnt1), transcript variant 1, 200 uL, >10^7 TU/mL |
|
 |
200 µl /
€1,230.00
|
|
| OriGene Technologies, Inc. | ||
| MR208543L2V | Lenti ORF particles, B4galnt1 (GFP-tagged) - Mouse beta-1,4-N-acetyl-galactosaminyl transferase 1 (B4galnt1), transcript variant 2, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€1,230.00
|
|
| OriGene Technologies, Inc. | ||
| MR208544L1V | Lenti ORF particles, B4galnt1 (Myc-DDK-tagged) - Mouse beta-1,4-N-acetyl-galactosaminyl transferase 1 (B4galnt1), transcript variant 1, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€1,100.00
|
|
| OriGene Technologies, Inc. | ||
| MR208543L1V | Lenti ORF particles, B4galnt1 (Myc-DDK-tagged) - Mouse beta-1,4-N-acetyl-galactosaminyl transferase 1 (B4galnt1), transcript variant 2, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€1,100.00
|
|
| OriGene Technologies, Inc. | ||
Rat Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| RR200805L2V | Lenti ORF particles, B4galnt1 (GFP-tagged ORF) - Rat beta-1,4-N-acetyl-galactosaminyl transferase 1 (B4galnt1), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€1,230.00
|
|
| OriGene Technologies, Inc. | ||
| RR200805L1V | Lenti ORF particles, B4galnt1 (Myc-DDK-tagged ORF) - Rat beta-1,4-N-acetyl-galactosaminyl transferase 1 (B4galnt1), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€1,110.00
|
|
| OriGene Technologies, Inc. | ||